Transdermal fentanyl for pain caused by radiotherapy in head and neck cancer patients treated in an outpatient setting: A multicenter trial in Taiwan

Japanese Journal of Clinical Oncology

Volumn 40, Issue 4, 2009, Pages 307-312

  Chang, Joseph Tung Chieh ^a,b   Lin, Chien Yu ^a,b   Lin, Jin Ching ^c   Lee, Moon Sing ^d   Chen, Yu Jen ^e   Wang, Hung Ming ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d Dalin Tzu Chi General Hospital   (Taiwan)

^e MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Head and neck cancer; Radiotherapy; Transdermal fentanyl

Indexed keywords

CODEINE PHOSPHATE; FENTANYL; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; TRAMADOL; NARCOTIC ANALGESIC AGENT;

ADULT; AGED; ARTICLE; BRIEF PAIN INVENTORY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OUTPATIENT; PAIN; RADIATION DOSE; SOMNOLENCE; TRANSDERMAL PATCH; VISUAL ANALOG SCALE; VOMITING; HEAD AND NECK TUMOR; INTRADERMAL DRUG ADMINISTRATION; MIDDLE AGED; PAIN ASSESSMENT; RADIOTHERAPY; TAIWAN;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; ANALGESICS, OPIOID; FEMALE; FENTANYL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PAIN; PAIN MEASUREMENT; RADIOTHERAPY; TAIWAN; YOUNG ADULT;

EID: 77951249167     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyp166     Document Type: Article

References (21)

1. Brizel DM. Radiotherapy and concurrent chemotherapy for the treatment of locally advanced head and neck squamous cell carcinoma. Semin Radiat Oncol 1998;8:237-46.
2. Bartelink H, Schellens JH, Verheij M. The combined use of radiotherapy and chemotherapy in the treatment of solid tumours. Eur J Cancer 2002;38:216-22.
3. Fu KK. Combined radiotherapy and chemotherapy for nasopharyngeal carcinoma. Semin Radiat Oncol 1998;8:247-53.
4. Vokes EE, Awan AM, Weichselbaum RR. Radiotherapy with concomitant chemotherapy for head and neck cancer. Hematol Oncol Clin North Am 1991;5:753-67.
5. Browman GP, Hodson DI, Mackenzie RJ, Bestic N, Zuraw L. Cancer Care Ontario Practice Guideline Initiative Head and Neck Cancer Disease Site Group. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis. Head Neck 2001;23:579-89.
6. Ressel A, Schmitt O, Weiss C, Feyerabend T. Therapeutic outcome and side-effects after radiotherapy, chemotherapy and/or hyperthermia treatment of head and neck tumour xenografts. Eur J Cancer 2002;38:594-601.
7. Ohrn KE, Wahlin YB, Sjoden PO. Oral status during radiotherapy and chemotherapy: a descriptive study of patient experiences and the occurrence of oral complications. Support Care Cancer 2001;9: 247-57.
8. Plevova P. Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review. Oral Oncol 1999; 35:453-70.
9. Lazarus CL, Logemann JA, Pauloski BR, Colangelo LA, Kahrilas PJ, Mittal BB, et al. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope 1996;106:1157-66.
10. List MA, Mumby P, Haraf D, Siston A, Mick R, MacCracken E, et al. Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer. Qual Life Res 1997;6:274-84.
11. Mystakidou K, Befon S, Tsilika E, Dardoufas K, Georgaki S, Vlahos L. Use of TTS fentanyl as a single opioid for cancer pain relief: a safety and efficacy clinical trial in patients naive to mild or strong opioids. Oncology 2002;62:9-16.
12. Huang HY, Wilkie DJ, Chapman CR, Ting LL. Pain trajectory of Taiwanese with nasopharyngeal carcinoma over the course of radiation therapy. J Pain Symptom Manage 2003;25:247-55.
13. Ger LP, Ho ST, Wang JJ. Physicians' knowledge and attitudes toward the use of analgesics for cancer pain management: a survey of two medical centers in Taiwan. J Pain Symptom Manage 2000;20:335-44.
14. Hsu TH, Lu MS, Tsou TS, Lin CC. The relationship of pain, uncertainty, and hope in Taiwanese lung cancer patients. J Pain Symptom Manage 2003;26:835-42.
15. Browman GP, Levine MN, Hodson DI, Sathya J, Russell R, Skingley P, et al. The Head and Neck Radiotherapy Questionnaire: a morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer. J Clin Oncol 1993;11:863-72.
16. Huang HY, Wilkie DJ, Schubert MM, Ting LL. Symptom profile of nasopharyngeal cancer patients during radiation therapy. Cancer Pract 2000;8:274-81.
17. Wilson PR, Herman J, Chubon SJ. Eating strategies used by persons with head and neck cancer during and after radiotherapy. Cancer Nurs 1991;14:98-104.
18. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129-38.
19. Thienthong S, Pratheepawanit N, Limwattananon C, Maoleekoonpairoj S, Lertsanguansinchai P, Chanvej L. Pain and quality of life of cancer patients: a multi-center study in Thailand. J Med Assoc Thai 2006;89:1120-6.
20. Mystakidou K, Tsilika E, Parpa E, Kouloulias V, Kouvaris I, Georgaki S, et al. Long-term cancer pain management in morphine pre-treated and opioid naive patients with transdermal fentanyl. Int J Cancer 2003;107:486-92.
21. Komurcu S, Turhal S, Altundag K, Atahan L, Turna HS, Manavoglu O, et al. Safety and efficacy of transdermal fentanyl in patients with cancer pain: phase IV, Turkish oncology group trial. Eur J Cancer Care (Engl) 2007;16:67-73.